Jean-Michel Vernier

Jean-Michel Vernier

Corporate Officer/Principal chez Ignyta Operating, Inc.

63 ans
Health Technology
Consumer Services

Profil

Jean-Michel Vernier is the founder of Selexagen Therapeutics, Inc. He currently holds the position of Vice President-Medicinal Chemistry at Ignyta Operating, Inc. Vernier has previously worked as Associate Director-Chemistry at Bausch Health Americas, Inc., Senior Research Scientist at Sibia Neurosciences, Inc., Vice President-Discovery Chemistry at Ardea Biosciences, Inc., and Senior Chemistry Investigator at Merck Research Laboratories Massachusetts LLC.
He has also held the position of Head-Medicinal Chemistry at Aravive Biologics, Inc. from 2012 to 2013 and Vice President-Chemistry Department at Ignyta, Inc. from 2013 to 2018.
Vernier holds a doctorate degree from the University of Strasbourg.

Postes actifs de Jean-Michel Vernier

SociétésPosteDébut
Corporate Officer/Principal 01/06/2013
Tous les postes actifs de Jean-Michel Vernier

Anciens postes connus de Jean-Michel Vernier

SociétésPosteFin
IGNYTA INC Corporate Officer/Principal 01/12/2018
Corporate Officer/Principal 01/04/2013
Sibia Neurosciences, Inc. Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Voir l'expérience en détail de Jean-Michel Vernier

Formation de Jean-Michel Vernier

University of Strasbourg Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Jean-Michel Vernier

Relations

28

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées8

Health Technology

Health Technology

Health Technology

Selexagen Therapeutics, Inc.

Health Technology

Health Technology

Sibia Neurosciences, Inc.

Health Technology

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Jean-Michel Vernier